User:Mr. Ibrahem/Alectinib

Alectinib, sold under the brand name Alecensa, is a medication used to treat non-small-cell lung cancer (NSCLC). It is used for advanced disease that is anaplastic lymphoma kinase (ALK) positive. It is taken by mouth.

Common side effects include tiredness, constipation, swelling, muscle pain, and low red blood cells. Other side effects may include liver problems, pneumonitis, kidney problems, and muscle breakdown. Use in pregnancy may harm the baby. It is a tyrosine kinase inhibitor that blocks ALK.

Alectinib was approved in Japan in 2014, the United States in 2015, and Europe in 2017. In the United Kingdom 4 weeks costs the NHS about £5,000 as of 2021. This amount in the United States is about 16,000 USD.